These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 23644204)
1. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation. Li D; Xu S; Cai H; Pei L; Zhang H; Wang L; Yao H; Wu X; Jiang J; Sun Y; Xu J Eur J Med Chem; 2013 Jun; 64():215-21. PubMed ID: 23644204 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells. Li D; Cai H; Jiang B; Liu G; Wang Y; Wang L; Yao H; Wu X; Sun Y; Xu J Eur J Med Chem; 2013 Jan; 59():322-8. PubMed ID: 23274570 [TBL] [Abstract][Full Text] [Related]
3. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents. Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090 [TBL] [Abstract][Full Text] [Related]
4. Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents. Li D; Xu S; Cai H; Pei L; Wang L; Wu X; Yao H; Jiang J; Sun Y; Xu J ChemMedChem; 2013 May; 8(5):812-8. PubMed ID: 23520191 [TBL] [Abstract][Full Text] [Related]
5. Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation. Hu X; Bai Z; Qiao J; Li H; Xu S; Wang X; Xu Y; Xu J; Hua H; Li D Eur J Med Chem; 2019 Jun; 171():169-179. PubMed ID: 30921757 [TBL] [Abstract][Full Text] [Related]
6. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics. Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, Cytotoxicity and Antimicrobial Activity of New Enmein-type Kauranoid Diterpenoid Derivatives. Li D; Han T; Hu X; Tian K; Xu S; Zhou T; Cheng K; Li Z; Hua H; Xu J Anticancer Agents Med Chem; 2017; 17(12):1679-1688. PubMed ID: 28403782 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity. Hou W; Fan Q; Su L; Xu H Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049 [TBL] [Abstract][Full Text] [Related]
9. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies. Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140 [TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide releasing enmein-type diterpenoid derivatives as apoptosis inducers through mitochondria-related pathways. Xu F; Gao X; Li H; Xu S; Li X; Hu X; Li Z; Xu J; Hua H; Li D Bioorg Chem; 2019 Feb; 82():192-203. PubMed ID: 30326401 [TBL] [Abstract][Full Text] [Related]
11. Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells. Luo D; Yi Y; Peng K; Liu T; Yang J; Liu S; Zhao W; Qu X; Yu W; Gu Y; Wan S Eur J Med Chem; 2019 Sep; 178():365-379. PubMed ID: 31200238 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents. Ke Y; Liang JJ; Hou RJ; Li MM; Zhao LF; Wang W; Liu Y; Xie H; Yang RH; Hu TX; Wang JY; Liu HM Eur J Med Chem; 2018 Sep; 157():1249-1263. PubMed ID: 30193221 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway. Shen QK; Deng H; Wang SB; Tian YS; Quan ZS Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113 [TBL] [Abstract][Full Text] [Related]
14. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage. Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811 [TBL] [Abstract][Full Text] [Related]
15. Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action. Liu JJ; Huang RW; Lin DJ; Wu XY; Peng J; Pan XL; Lin Q; Hou M; Zhang MH; Chen F Am J Hematol; 2006 Feb; 81(2):86-94. PubMed ID: 16432862 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates. Xu J; Yang J; Ran Q; Wang L; Liu J; Wang Z; Wu X; Hua W; Yuan S; Zhang L; Shen M; Ding Y Bioorg Med Chem Lett; 2008 Aug; 18(16):4741-4. PubMed ID: 18644718 [TBL] [Abstract][Full Text] [Related]
17. Isolation, synthesis, and anti-tumor activities of a novel class of podocarpic diterpenes. Xiong Y; Wang K; Pan Y; Sun H; Tu J Bioorg Med Chem Lett; 2006 Feb; 16(4):786-9. PubMed ID: 16309905 [TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties. Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992 [TBL] [Abstract][Full Text] [Related]
19. Semisynthesis and in vitro anticancer activities of andrographolide analogues. Jada SR; Subur GS; Matthews C; Hamzah AS; Lajis NH; Saad MS; Stevens MF; Stanslas J Phytochemistry; 2007 Mar; 68(6):904-12. PubMed ID: 17234223 [TBL] [Abstract][Full Text] [Related]
20. Bioactive enmein-type 6,7-seco-ent-kaurane diterpenoids: natural products, synthetic derivatives and apoptosis related mechanism. Li H; Sun B; Wang M; Hu X; Gao X; Xu S; Xu Y; Xu J; Hua H; Li D Arch Pharm Res; 2018 Nov; 41(11):1051-1061. PubMed ID: 30242610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]